Vaxxa AB reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 9.95 million compared to SEK 12.47 million a year ago. Revenue was SEK 10.51 million compared to SEK 12.68 million a year ago. Net loss was SEK 0.799 million compared to SEK 6.71 million a year ago.
For the nine months, sales was SEK 26.13 million compared to SEK 30.63 million a year ago. Revenue was SEK 27.61 million compared to SEK 31.57 million a year ago. Net loss was SEK 4.39 million compared to SEK 14.53 million a year ago.